Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Histochem ; 56(4): e43, 2012 Oct 08.
Article in English | MEDLINE | ID: mdl-23361239

ABSTRACT

In a previous study, we reported that the short-term treatment with celecoxib, a non-steroidal anti-inflammatory drug (NSAID) attenuates the activation of brain structures related to nociception and does not interfere with orthodontic incisor separation in rats. The conclusion was that celecoxib could possibly be prescribed for pain in orthodontic patients. However, we did not analyze the effects of this drug in periodontium. The aim of this follow-up study was to analyze effects of celecoxib treatment on recruitment and activation of osteoclasts and alveolar bone resorption after inserting an activated orthodontic appliance between the incisors in our rat model. Twenty rats (400-420 g) were pretreated through oral gavage with celecoxib (50 mg/kg) or vehicle (carboxymethylcellulose 0.4%). After 30 min, they received an activated (30 g) orthodontic appliance, set not to cause any palate disjunction. In sham animals, the appliance was immediately removed after introduction. All animals received ground food and, every 12 h, celecoxib or vehicle. After 48 h, they were anesthetized and transcardiacally perfused through the aorta with 4% formaldehyde. Subsequently, maxillae were removed, post-fixed and processed for histomorphometry or immunohistochemical analyses. As expected, incisor distalization induced an inflammatory response with certain histological changes, including an increase in the number of active osteoclasts at the compression side in group treated with vehicle (appliance: 32.2 ± 2.49 vs sham: 4.8 ± 1.79, P<0.05) and celecoxib (appliance: 31.0 ± 1.45 vs sham: 4.6 ± 1.82, P<0.05). The treatment with celecoxib did not modify substantially the histological alterations and the number of active osteoclasts after activation of orthodontic appliance. Moreover, we did not see any difference between the groups with respect to percentage of bone resorption area. Taken together with our previous results we conclude that short-term treatment with celecoxib can indeed be a therapeutic alternative for pain relieve during orthodontic procedures.


Subject(s)
Cyclooxygenase 2 Inhibitors/pharmacology , Osteoclasts/drug effects , Pyrazoles/pharmacology , Sulfonamides/pharmacology , Tooth Movement Techniques , Animals , Bone Resorption , Celecoxib , Cyclooxygenase 2 Inhibitors/therapeutic use , Follow-Up Studies , Models, Animal , Orthodontic Appliances , Osteoclasts/cytology , Pain/drug therapy , Pyrazoles/therapeutic use , Rats , Sulfonamides/therapeutic use , Time Factors
2.
Brain Res Bull ; 79(6): 396-401, 2009 Aug 14.
Article in English | MEDLINE | ID: mdl-19463908

ABSTRACT

Non-steroidal anti-inflammatory drugs (NSAIDs) have been used for pain relief in orthodontics, but clinical studies reported that they may reduce tooth movement (TM). By other side, TM seems to activate brain structures related to nociception, but the effects of NSAIDs in this activation have not been studied yet. We analyzed the effect of short-term treatment with acetaminophen or celecoxib in the separation of rat upper incisors, as well as in neuronal activation of the spinal trigeminal nucleus, following tooth movement. Thirty rats (400-420 g) were pretreated through oral gavage (1 ml/dose) with acetaminophen (200mg/kg), celecoxib (50mg/kg) or vehicle (carboxymethylcellulose 0.4%). After 30 min, they received an activated (30 g) orthodontic appliance for TM. In controls, this appliance was immediately removed after its introduction. Rats received ground food, and every 12h, one of the drugs or vehicle. After 48 h, they were anesthetized, maxilla was radiographed, and were perfused with 4% paraformaldehyde. Brains were further processed for Fos immunohistochemistry. TM induced incisor distalization (p<0.05) and neuronal activation of the spinal trigeminal nucleus. Treatment with both drugs did not affect tooth movement, but reduced c-fos expression in the caudalis subnucleus. No changes in c-fos expression were seen in the oralis and interpolaris subnuclei. We conclude that neither celecoxib nor acetaminophen seems to affect tooth movement, when used for 2 days, but both drugs are able to reduce the activation of brain structures related to nociception. Short-term treatment with celecoxib, thus, may be a therapeutic alternative to acetaminophen when the latter is contraindicated.


Subject(s)
Acetaminophen/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Neurons/drug effects , Pyrazoles/pharmacology , Sulfonamides/pharmacology , Tooth Movement Techniques , Trigeminal Nucleus, Spinal/drug effects , Analysis of Variance , Animals , Brain/drug effects , Brain/metabolism , Celecoxib , Gene Expression/drug effects , Immunohistochemistry , Incisor , Male , Maxilla/diagnostic imaging , Maxilla/drug effects , Neurons/metabolism , Proto-Oncogene Proteins c-fos/genetics , Proto-Oncogene Proteins c-fos/metabolism , Radiography , Rats , Rats, Wistar , Trigeminal Nucleus, Spinal/metabolism
3.
J Dent Res ; 83(1): 50-4, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14691113

ABSTRACT

In the rat experimental model, molar tooth movement induced by Waldo's method is known to cause a temporally and spatially defined pattern of brain neuronal activation. Since orthodontic correction usually involves the entire dental arch, we used a spring-activated appliance to extend the investigation to incisors, and we included brain regions related to antinociception. Adjustment of the non-activated appliance on incisors resulted in c-fos expression in the dorsal raphe, peri-aqueductal gray matter, and the locus coeruleus, in addition to trigeminal sensory subnuclei and the parabrachial nucleus, where neuronal activation has already been detected in previous studies on molar tooth movement. Appliance activation with a 70-g force resulted in a further increase in Fos-immunoreactive neurons in the trigeminal sensory subnucleus caudalis and in the dorsal raphe. This result suggests that there is a recruitment of neurons related to nociception and to antinociception when tooth movement is increased.


Subject(s)
Brain/metabolism , Genes, fos/genetics , Incisor/pathology , Proto-Oncogene Proteins c-fos/analysis , Tooth Movement Techniques , Analgesics/pharmacology , Animals , Brain/pathology , Genes, fos/drug effects , Ketamine/pharmacology , Locus Coeruleus/metabolism , Locus Coeruleus/pathology , Male , Models, Animal , Neurons/metabolism , Neurons/ultrastructure , Nociceptors/metabolism , Nociceptors/ultrastructure , Orthodontic Appliances , Pain/genetics , Periaqueductal Gray/metabolism , Periaqueductal Gray/pathology , Proto-Oncogene Proteins c-fos/drug effects , Rats , Rats, Wistar , Recruitment, Neurophysiological/genetics , Reticular Formation/metabolism , Reticular Formation/pathology , Tooth Movement Techniques/instrumentation , Trigeminal Nuclei/metabolism , Trigeminal Nuclei/pathology , Xylazine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...